Epidemiology of gestational trophoblastic diseases

Bailliere's Best Practice and Research in Clinical Obstetrics and Gynaecology

Volumn 17, Issue 6, 2003, Pages 837-847

  Steigrad, Stephen James ^a  

^a ROYAL HOSPITAL FOR WOMEN   (Australia)

Author keywords

Aetiology; Epidemiology; Gestational trophoblastic diseases; Incidence

Indexed keywords

ANTINEOPLASTIC AGENT; CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; LUTEINIZING HORMONE; ORAL CONTRACEPTIVE AGENT;

ANAMNESIS; BIOCHEMISTRY; BIRTH RATE; CONTRACEPTION; CURETTAGE; DIAGNOSTIC IMAGING; ECHOGRAPHY; ETHNOLOGY; FERTILIZATION; FOLLOW UP; GAMETOGENESIS; GENETICS; GEOGRAPHIC DISTRIBUTION; GESTATION PERIOD; HORMONE DETERMINATION; HYDATIDIFORM MOLE; INCIDENCE; MALIGNANT TRANSFORMATION; MATERNAL AGE; PREGNANCY; PREGNANCY TERMINATION; PRIORITY JOURNAL; REVIEW; TROPHOBLASTIC DISEASE; TROPHOBLASTIC TUMOR; X RAY;

EID: 0346392790     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1521-6934(03)00049-X     Document Type: Review

References (77)

1. Grimes D. Epidemiology of gestational trophoblastic disease. American Journal of Obstetrics and Gynecology 1984; 150: 309-318.
2. Bracken MB, Brinton LA & Hayashi K. Epidemiology of hydatidiform mole and choriocarcinoma. Epidemiological Reviews 1984; 6: 52-75.
3. Bracken MB. Incidence and aetiology of hydatidiform mole; An epidemiological review. British Journal of Obstetrics and Gynaecology 1987; 94: 1123-1135.
4. Palmer JR. Advances in the epidemiology of gestational trophoblastic disease. Journal of Reproductive Medicine 1994; 39: 155-162.
5. National Coordination Research Group for Choriocarcinoma, Incidence of hydatidiform mole (a retrograde study of 2 023 621 women in 23 provinces). Chung-Hua i Hsueh Tsa Chih (Chinese Medical Journal) 1980; 60: 641-645.
6. Shang E, Xu L & Wei M. A retrospective study on incidence of hydatidiform mole in 20 548 fertile women. Chung-Hua i Hsueh Tsa Chih (Chinese Medical Journal) 1982; 62: 282-285.
7. Song H & Wu P. Hydatidiform mole in China: A preliminary survey of incidence of more than three million women. Bulletin of the World Health Organisation 1987; 65: 507-511.
8. Nakano R, Sasaki K, Yamoto M et al. Trophoblastic disease; Analysis of 342 patients. Gynaecologic and Obstetric Investigation 1980; 11: 237-242.
9. Honda J, Yanagida L, Sato E et al. Incidence of hydatidiform mole and aging of mothers. Nippon Sanka Fujinka Gakkai Zasshi 1982; 34: 915-919. (Author's translation).
10. Takeuchi S. Incidence of gestational trophoblastic disease by regional registration in Japan. Human Reproduction 1987; 2: 729-734.
11. Poen HT & Djojopranoto M. The possible aetiological factors of hydatidiform and choriocarcinoma. American Journal of Obstetrics and Gynecology 1965; 95: 510-513.
12. Aziz MF, Kampono N, Moegni EM et al. Epidemiology of gestational trophoblastic neoplasm at the Dr. Cipto Mandunkusumo Hospital, Jakarta, Indonesia. Advances in Experimental Medicine and Biology 1984; 176: 165-175.
13. Prabha B, Molykutty J & Krishnan Nair M. Gestational trophoblastic diseases as a clinical entity - A review. Journal of Experimental and Clinical Cancer Research 1995; 14: 239-246.
14. Gul T & Yilmazturk A. A review of trophoblastic diseases at the medical school of Dicle University. European Journal of Obstetrics, Gynaecology and Reproductive Biology 1997; 74: 37-40.
15. Hayashi K, Bracken MB, Freeman Jr. DH & Hellenbrand K. Hydatidiform mole in the United States (1970-1977) a statistical and theoretical analysis. American Journal of Epidemiology 1982; 115: 67-77.
16. Atrash HK, Hogue CJR & Grimes DA. Epidemiology of hydatidiform mole during early gestation. American Journal of Obstetrics and Gynecology 1986; 154: 906-909.
17. Womack C & Elston CW. Hydatidiform mole in Nottingham: A 12-year retrospective epidemiological and morphological survey. Placenta 1985; 6: 93-105.
18. Bagshawe KD, Dent J & Webb J. Hydatidiform mole in England and Wales. Lancet 1986; 2: 673-677.
19. Mazzanti P, La Vecchia C, Parazzini F et al. Frequency of hydatidiform mole in Lombardy, Northern Italy. Gynecologic Oncology 1986; 24: 337-342.
20. Franke HR, Risse EKJ, Kenemans P et al. Epidemiologic features of hydatidiform mole in the Netherlands. Obstetrics and Gynecology 1983; 62: 613-616.
21. Flam F, Lundstrom-Lindstedt V & Rutqvist LE. Incidence of gestational trophoblastic disease in Stockholm County. European Journal of Epidemiology 1992; 8: 173-177.
22. Olesnicky G, Long AR, Quinn MA et al. Hydatidiform mole in Victoria: Aetiology and natural history. Australian and New Zealand Journal of Obstetrics and Gynaecology 1985; 25: 1-7.
23. Duff GB. Gestational trophoblastic disease in New Zealand, 1980-1986. Australian and New Zealand Journal of Obstetrics and Gynaecology 1989; 29: 139-142.
24. Paksoy N & Reich B. The occurrence of trophoblastic disease in Western Samoa. New Zealand Medical Journal 1989; 102: 162-163.
25. Steigrad SJ. The incidence of neoplastic trophoblastic disease in Australia. Australian and New Zealand Journal of Obstetrics and Gynaecology 1969; 9: 100-102.
26. Rolon PA & De Lopez BH. Epidemiological aspects of hydatidiform mole in the Republic of Paraguay (South America). British Journal of Obstetrics and Gynaecology 1977; 84: 862-864.
27. Ogunbode O. Benign hydatidiform mole in Ibadan, Nigeria. International Journal of Gynaecology and Obstetrics 1978; 15: 387-390.
28. Agboola A. Trophoblastic neoplasia in an African urban population. Journal of the National Medical Association 1979; 71: 935-937.
29. Ayangade O. Gestational trophoblastic disease in Nigeria - A 10-year review. East African Medical Journal 1979; 56: 278-282.
30. Diejomaoh FM, Omu AE, Okpere EE et al. Problems of management of gestational neoplasms at the University of Benin Teaching Hospital, Benin City, Nigeria. Advances in Experimental Medicine and Biology 1984; 176: 417-428.
31. Egwuatu VE & Ozumba BC. Observations on molar pregnancy in Enugu, Nigeria. International Journal of Gynaecology and Obstetrics 1989; 29: 219-225.
32. Leighton PC. Trophoblastic disease in Uganda. American Journal of Obstetrics and Gynecology 1973; 117: 341-344.
33. Acosta-Sison H. Observation which may indicate the aetiology of hydatidiform mole and explain its high incidence in the Philippines and Asiatic countries. Philippine Journal of Surgery 1959; 14: 290-293.
34. Martin BH & Kim JH. Changes in gestational trophoblastic tumours over four decades. A Korean Experience. Journal of Reproductive Medicine 1998; 43: 60-68.
35. Kim SJ, Bae SN, Kim JH et al. Epidemiology and time trends of gestational trophoblastic disease in Korea. International Journal of Gynaecology and Obstetrics 1998; 60(supplement 1): S33-S38.
36. Hando T, Ohno M & Kurose T. Recent aspects of gestational trophoblastic disease in Japan. International Journal of Gynaecology and Obstetrics 1998; 60(supplement 1): S71-S76.
37. Wang JC, Wang PH & Yuan CC. Review of trophoblastic disease at Taipei Veterans General Hospital. Chung Hua i Hsueh Tsa Chih (Chinese Medical Journal) 2000; 63: 399-406.
38. Nielson NH & Hansen JPH. Trophoblastic tumours in Greenland. Journal of Cancer Research and Clinical Oncology 1979; 95: 177-186.
39. Teoh ES, Dawood MY & Ratnam SS. Epidemiology of hydatidiform mole in Singapore. American Journal of Obstetrics and Gynecology 1971; 110: 415-420.
40. Ringertz N. Hydatidiform mole, invasive mole and choriocarcinoma in Sweden 1958-1965. Acta Obstetricia et Gynecologica Scandinavica 1970; 49: 195-203.
41. Bandy LC, Clarke-Pearson DL & Hammond CB. Malignant potential of gestational trophoblastic disease at the extreme ages of reproductive life. Obstetrics and Gynecology 1984; 64: 395-399.
42. Bayatpour M & Reyes J. Gestational trophoblastic disease among adolescents. Adolescent and Pediatric Gynecology 1993; 6: 220-222.
43. La Vecchia CL, Franceschi S, Parazzini F et al. Risk factors for gestational trophoblastic disease in Italy. American Journal of Epidemiology 1985; 121: 457-464.
44. Matsuura J, Chiu D, Jacobs PA et al. Complete hydatidiform mole in Hawaii: An epidemiological study. Genetic Epidemiology 1984; 1: 271-284.
45. Yen S & MacMahon B. Epidemiologic features of trophoblastic disease. American Journal of Obstetrics and Gynecology 1968; 101: 126-132.
46. Pour Reza M, Agheli N & Baghefi SB. Serum creatinine, urea and protein level changes in hydatidiform mole. Journal of the American Medical Association 1974; 230: 580-581.
47. Martin PM. High frequency of hydatidiform mole in native Alaskans. International Journal of Gynaecology and Obstetrics 1978; 15: 395-396.
48. MacGregor C, Ontiveros E, Vargas E & Valenzuela S. Hydatidiform mole. Obstetrics and Gynaecology 1969; 33: 343-351.
49. Matalon M & Modan B. Epidemiologic aspects of hydatidiform mole in Israel. American Journal of Obstetrics and Gynecology 1972; 112: 107-112.
50. Berkowitz RS & Goldstein DP. Pathogenesis of gestational trophoblastic neoplasms. Pathobiology Annual 1981; 11: 391-411.
51. Sand PK, Lurain JR & Brewer JI. Repeat gestational trophoblastic disease. Obstetrics and Gynaecology 1984; 63: 140-144.
52. Matsui H, Iitsuka Y, Suzuka K et al. Subsequent pregnancy outcome in patients with spontaneous resolution of hCG after evacuation of hydatidiform mole, comparison between complete and partial mole. Human Reproduction 2001; 16: 1274-1277.
53. McFadden DE, Jiang R, Langlois S & Robinson WP. Dispermy - Origin of diandric triploidy. Human Reproduction 2002; 17: 3037-3038.
54. Zaragoza MV, Surt U, Redline RW et al. Parental origin and phenotype of triploidy in spontaneous abortions: Predominance of diandry and association with partial hydatidiform mole. American Journal of Human Genetics 2000; 66: 1807-1820.
55. Pal L, Toth TL, Leykin L & Isaacson KB. High incidence of triploidy in in-vitro fertilised oocytes from a patient with a previous history of recurrent gestational trophoblastic disease. Human Reproduction 1996; 11: 1529-1532.
56. Cheah PL, Looi LM & Sivanesaratnam V. Hydatidiform molar pregnancy in Malaysian women: A histopathological study from the University Hospital, Kuala Lumpur. Malaysian Journal of Pathology 1993; 15: 59-63.
57. Palmer JR, Driscoll SG, Rosenberg L et al. Oral contraceptive use and risk of gestational trophoblastic tumours. Journal of the National Cancer Institute 1999; 91: 635-640.
58. Berkowitz RS, Cramer DW, Bernstein MR et al. Risk factors for complete molar pregnancy from a case control study. American Journal of Obstetrics and Gynecology 1985; 152: 1016-1020.
59. Messerli ML, Lilienfeld AM, Parmley T et al. Risk factors for gestational trophoblastic neoplasia. American Journal of Obstetrics and Gynecology 1985; 153: 294-300.
60. Brinton LA, Wu BZ, Wang W et al. Gestational trophoblastic disease: A case controlled study from the People's Republic of China. American Journal of Obstetrics and Gynecology 1989; 161: 121-127.
61. Pai KN. A study of choriocarcinoma. Its incidence in India and its aetiopathogenesis. In Holland JF & Hreshchyshyn MM (eds) Choriocarcinoma. Berlin: Springer, 1967, pp 54-57.
62. Chan DPC. Chorionepithelioma. A study of 41 cases. British Medical Journal 1962; 2: 953-956.
63. Nakano R, Sasaki K, Yamoto M & Hata H. Trophoblastic disease: Analysis of 342 patients. Gynecologic and Obstetric Investigation 1980; 11: 237-242.
64. Brewer JI & Gerbie AB. Early development of choriocarcinoma. In Holland JF & Hreshchyshyn MM (eds) Choriocarcinoma. Berlin: Springer, 1967, pp 45-53.
65. Matalon M, Paz B, Modan M & Modan B. Malignant trophoblastic disorders. American Journal of Obstetrics and Gynecology 1972; 112: 101-106.
66. Rolon PA & De Lopez BH. Malignant trophoblastic disease in Paraguay. Journal of Reproductive Medicine 1979; 23: 94-96.
67. Aranda JM & Martinez I. Choriocarcinoma in Puerto Rico. Boletin-Asociacion Medica De Puerto Rico 1968; 60: 523-535.
68. Shanmugaratnam K, Muir CS, Tow SH et al. Rates per 100 000 births and incidence of choriocarcinoma and malignant mole in Singapore Chinese and Malays. International Journal of Cancer 1971; 8: 165-175.
69. Teoh ES, Dawood MY & Ratnam SS. Observations on choriocarcinoma in Singapore. Obstetrics and Gynaecology 1972; 40: 519-524.
70. Bagshawe KD. Recent observations related to the chemotherapy and immunology of gestational choriocarcinoma. Advances in Cancer Research 1973; 18: 231-263.
71. Curry SL, Schlaerth JB, Kohorn EI et al. Hormonal contraception and trophoblastic sequelae after hydatidiform mole (a Gynecologic Oncology Group Study). American Journal of Obstetrics and Gynecology 1989; 160: 805-809.
72. Deicas RE, Miller DS, Rademaker AW et al. The role of contraception in the development of post-molar gestational trophoblastic tumour. Obstetrics and Gynecology 1991; 78: 221-226.
73. Morrow P, Nakamura R, Schlaerth J et al. The influence of oral contraceptives on the post-molar human chorionic gonadotrophin regression curve. American Journal of Obstetrics and Gynecology 1985; 151: 906-914.
74. Baltazar JC. Epidemiological features of choriocarcinoma. Bulletin of the World Health Organization 1976; 54: 523-532.
75. Rosenberg L, Palmer JR & Shapiro S. Gestational trophoblastic disease and use of oral contraceptives. American Journal of Obstetrics and Gynecology 1989; 161: 1087-1088.
76. Cohen BA, Burkman RT, Rosenshein NB et al. Gestational trophoblastic disease within an elective abortion population. American Journal of Obstetrics and Gynecology 1979; 135: 452-454.
77. Yuen BH & Callegari PB. Occurrence of molar pregnancy in patients undergoing elective abortion: Comparison with other clinical presentations. American Journal of Obstetrics and Gynecology 1986; 154: 273-276.